Serious QT interval prolongation with ranolazine and amiodarone.

导出 LinkOut

翻译打印收藏纠错

作者： Mónica,Tarapués ^[1] ; Gloria,Cereza ^[2] ; Ana Lucía,Arellano ^[3] ; Eva,Montané ^[4] ; Albert,Figueras ^[5]

作者单位： Pharmacology, Therapeutics and Toxicology Department, UniversitatAutònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès), Spain. Electronic address: mtr@icf.uab.cat. ^[1] Pharmacology, Therapeutics and Toxicology Department, UniversitatAutònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès), Spain; FundacióInstitutCatalà de Farmacologia, PasseigValld'Hebron 119-129, 08035 Barcelona, Spain; Catalan Centre of Pharmacovigilance, Barcelona, Spain. ^[2] Clinical Pharmacology Department, Hospital Universitari Germans TriasiPujol, Carretera de Canyet s/n, 08916 Badalona, Spain. ^[3] Pharmacology, Therapeutics and Toxicology Department, UniversitatAutònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès), Spain; Clinical Pharmacology Department, Hospital Universitari Germans TriasiPujol, Carretera de Canyet s/n, 08916 Badalona, Spain. ^[4] Pharmacology, Therapeutics and Toxicology Department, UniversitatAutònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès), Spain; FundacióInstitutCatalà de Farmacologia, PasseigValld'Hebron 119-129, 08035 Barcelona, Spain. ^[5]

关键词 Adverse drug reaction Amiodarone Angina QT interval prolongation Ranolazine